CD4 and pulmonary arterial hypertension: Despite the well-known role of monocytes and myeloid cells in PAH response [7], CD4+ T cells have been understudied and are now emerging as key players in pulmonary vascular remodeling both in experimental [9–12] and clinical studies [13–16].